bpc-157 human clinical trials safety regulatory status bpc 157 peptide studies Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature bpc-157 human clinical trials evidence – The FDA is reviewing seven

Who should get a shot and who should avoid it

Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604

It reflects involvement of the posterior columns of the spinal cord

It contains no preservatives, artificial additives, or irritants